Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
What Is BPC-157 + TB-500
Convenient, though systemic exposure is lower than injectable
The laboratory-handling references for each compound live on their respective pages the cagrilintide research dosage reference and the retatrutide research dosage reference and the shared methodology of reconstitution and measurement is covered in the reconstitution guide
What youll see in the results Concentration after mixing (for example, mcg/mL) Draw volume per target amount (mL) Equivalent U100 syringe units (volume 100) Optional: approximate doses per vial (math only) Ready to Order
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
